New search | Conferencedetail
Print view

iPSC-Derived Cell Therapies Summit

Evvnt Promotion / evvnt
07.12.2021 - 09.12.2021  Virtual
Time: 9:00 am - 5:00 pm
Conference themes
Innovate The Next Generation of Safe, Scalable and Cost-Effective iPSC-Derived Therapies

The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing it’s place as the optimal starting material for cell therapies targeting cancer, autoimmune, cardiac disease and much more.
Professional congress organizer (PCO)
Hanson Wade

Speakers: Helen Tayton-Martin, CBO, Adaptimmune, Jo Brewer, Head of Allogenic Research, Adaptimmune, Andres Bratt-Leal, Co-Founder, Aspen Neuroscience and more

Enquiries and Registration:
Mr. Customer Services
Clinical Research, General Medicine
Congress fees
USD 1899.00 - USD 3597.00
Participants expected
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Swiss Tropical and Public Health InstituteHelix - Forschung & Beratung WienHilfswerk AustriaAnästhesie in Entwicklungsländern e. V.Österreichisches Rotes KreuzOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Charité International AcademyÄrzte der Welt